Importantly, however, the publications that have demonstrated positive effects of supra-physiologic levels of GM-CSF against IAV infection have used either constitutive expression models [3–5] or have administered GM-CSF either before [6, 28] or on the day of infection [5]. The gene discussed is CSF2; the disease is infection.